Asthma during Pregnancy: Exacerbations, Management, and Health Outcomes for Mother and Infant

Abstract

One in 10 pregnant women worldwide has asthma and of these, 10% will have a severe exacerbation requiring oral corticosteroids (OCSs) in pregnancy. This review of recent publications in the field will describe the effects of exacerbation on maternal and neonatal health, the use of asthma medications during pregnancy, and will suggest novel management approaches for asthma in pregnancy. Pregnancy results in unpredictable changes in the disease; therefore, regular monitoring of symptoms is recommended. Uncontrolled asthma is frequently described in cohorts of pregnant women with asthma, and some recent studies show associations with adverse perinatal outcomes, as previously demonstrated with exacerbations. Guidelines for the management of asthma recommend the continued use of inhaled corticosteroids (ICSs) in pregnancy, with budesonide having a particularly good safety profile. Recent data suggest small effects of asthma and/or asthma medication use on congenital malformations; however, there is less data available on the safety of ICS/long-acting β agonist combinations, which are increasingly used for maintenance treatment. Novel management strategies are needed to address the complex needs of pregnant women with asthma. These include medication nonadherence and the presence of numerous comorbidities which can affect asthma, such as rhinitis, cigarette smoking, obesity, and mental health issues. Inflammation-based management has been shown to be effective in reducing exacerbations in pregnancy and may also improve perinatal outcomes. The involvement of a multidisciplinary team and the assessment of comorbidities have potential to improve the health of mothers and their offspring.

Keywords

asthma - exacerbation - pregnancy - perinatal - inhaled corticosteroid - exhaled nitric oxide - management

• References

• 1 Hansen C, Joski P, Freiman H , et al. Medication exposure in pregnancy risk evaluation program: the prevalence of asthma medication use during pregnancy. Matern Child Health J 2013; 17 (9) 1611-1621
• 2 Rejnö G, Lundholm C, Gong T, Larsson K, Saltvedt S, Almqvist C. Asthma during pregnancy in a population-based study--pregnancy complications and adverse perinatal outcomes. PLoS One 2014; 9 (8) e104755
• 3 Sawicki E, Stewart K, Wong S, Paul E, Leung L, George J. Management of asthma by pregnant women attending an Australian maternity hospital. Aust N Z J Obstet Gynaecol 2012; 52 (2) 183-188
• 4 Adeyemi AS, Akinboro AO, Adebayo PB, Tanimowo MO, Ayodele OE. The prevalence, risk factors and changes in symptoms of self-reported asthma, rhinitis and eczema among pregnant women in Ogbomoso, Nigeria. J Clin Diagn Res 2015; 9 (9) OC01-OC07
• 5 Sunyer J, Torregrosa J, Anto JM , et al. The association between atopy and asthma in a semirural area of Tanzania (East Africa). Allergy 2000; 55 (8) 762-766
• 6 Kircher S, Schatz M, Long L. Variables affecting asthma course during pregnancy. Ann Allergy Asthma Immunol 2002; 89 (5) 463-466
• 7 Schatz M, Harden K, Forsythe A , et al. The course of asthma during pregnancy, post partum, and with successive pregnancies: a prospective analysis. J Allergy Clin Immunol 1988; 81 (3) 509-517
• 8 de Araujo GV, Leite DF, Rizzo JA, Sarinho ES. Asthma in pregnancy: association between the asthma control test and the global initiative for asthma classification and comparisons with spirometry. Eur J Obstet Gynecol Reprod Biol 2016; 203: 25-29
• 9 Grarup PA, Janner JH, Ulrik CS. Passive smoking is associated with poor asthma control during pregnancy: a prospective study of 500 pregnancies. PLoS One 2014; 9 (11) e112435
• 10 Zairina E, Abramson MJ, McDonald CF , et al. A prospective cohort study of pulmonary function during pregnancy in women with and without asthma. J Asthma 2016; 53 (2) 155-163
• 11 Schatz M, Dombrowski MP, Wise R , et al. Asthma morbidity during pregnancy can be predicted by severity classification. J Allergy Clin Immunol 2003; 112 (2) 283-288
• 12 Murphy VE, Clifton VL, Gibson PG. The effect of cigarette smoking on asthma control during exacerbations in pregnant women. Thorax 2010; 65 (8) 739-744
• 13 Kim S, Kim J, Park SY , et al. Effect of pregnancy in asthma on health care use and perinatal outcomes. J Allergy Clin Immunol 2015; 136 (5) 1215-23.e1 , 6
• 14 Lee CH, Kim J, Jang EJ , et al. Healthcare utilisation by pregnant patients with asthma in South Korea: a cohort study using nationwide claims data. BMJ Open 2015; 5 (11) e008416
• 15 Grzeskowiak LE, Smith B, Roy A, Dekker GA, Clifton VL. Patterns, predictors and outcomes of asthma control and exacerbations during pregnancy: a prospective cohort study. ERJ Open Res 2016; 2 (1) 00054-02015
• 16 Firoozi F, Ducharme FM, Lemière C , et al. Effect of fetal gender on maternal asthma exacerbations in pregnant asthmatic women. Respir Med 2009; 103 (1) 144-151
• 17 Ali Z, Nilas L, Ulrik CS. Low risk of adverse obstetrical and perinatal outcome in pregnancies complicated by asthma: a case control study. Respir Med 2016; 120: 124-130
• 18 Murphy VE, Clifton VL, Gibson PG. Asthma exacerbations during pregnancy: incidence and association with adverse pregnancy outcomes. Thorax 2006; 61 (2) 169-176
• 19 Baibergenova A, Thabane L, Akhtar-Danesh N, Levine M, Gafni A. Is fetal gender associated with emergency department visits for asthma during pregnancy?. J Asthma 2006; 43 (4) 293-299
• 20 Murphy VE, Gibson P, Talbot PI, Clifton VL. Severe asthma exacerbations during pregnancy. Obstet Gynecol 2005; 106 (5 Pt 1): 1046-1054
• 21 Powell H, Murphy VE, Taylor DR , et al. Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial. Lancet 2011; 378 (9795): 983-990
• 22 Bakhireva LN, Jones KL, Schatz M , et al; Organization of Teratology Information Specialists Collaborative Research Group. Safety of leukotriene receptor antagonists in pregnancy. J Allergy Clin Immunol 2007; 119 (3) 618-625
• 23 Juniper EF, Bousquet J, Abetz L, Bateman ED ; GOAL Committee. Identifying ‘well-controlled’ and ‘not well-controlled’ asthma using the asthma control questionnaire. Respir Med 2006; 100 (4) 616-621
• 24 National Asthma Council Australia. Australian Asthma Handbook. Available at: http://www.nationalasthma.org.au/handbook2015 . Accessed February 1, 2017
• 25 McCallister JW, Benninger CG, Frey HA, Phillips GS, Mastronarde JG. Pregnancy related treatment disparities of acute asthma exacerbations in the emergency department. Respir Med 2011; 105 (10) 1434-1440
• 26 Cydulka RK, Emerman CL, Schreiber D, Molander KH, Woodruff PG, Camargo Jr CA. Acute asthma among pregnant women presenting to the emergency department. Am J Respir Crit Care Med 1999; 160 (3) 887-892
• 27 Hasegawa K, Cydulka RK, Sullivan AF , et al. Improved management of acute asthma among pregnant women presenting to the ED. Chest 2015; 147 (2) 406-414
• 28 Cossette B, Beauchesne MF, Forget A , et al. Systemic corticosteroids for the treatment of asthma exacerbations during and outside of pregnancy in an acute-care setting. Respir Med 2014; 108 (9) 1260-1267
• 29 Powell H, McCaffery K, Murphy VE , et al. Psychosocial outcomes are related to asthma control and quality of life in pregnant women with asthma. J Asthma 2011; 48 (10) 1032-1040
• 30 Murphy VE, Namazy JA, Powell H , et al. A meta-analysis of adverse perinatal outcomes in women with asthma. BJOG 2011; 118 (11) 1314-1323
• 31 Murphy VE, Wang G, Namazy JA , et al. The risk of congenital malformations, perinatal mortality and neonatal hospitalisation among pregnant women with asthma: a systematic review and meta-analysis. BJOG 2013; 120 (7) 812-822
• 32 Wang G, Murphy VE, Namazy J , et al. The risk of maternal and placental complications in pregnant women with asthma: a systematic review and meta-analysis. J Matern Fetal Neonatal Med 2014; 27 (9) 934-942
• 33 Namazy JA, Murphy VE, Powell H, Gibson PG, Chambers C, Schatz M. Effects of asthma severity, exacerbations and oral corticosteroids on perinatal outcomes. Eur Respir J 2013; 41 (5) 1082-1090
• 34 Blais L, Kettani FZ, Forget A, Beauchesne MF, Lemière C. Asthma exacerbations during the first trimester of pregnancy and congenital malformations: revisiting the association in a large representative cohort. Thorax 2015; 70 (7) 647-652
• 35 National Heart, Lung, and Blood Institute; National Asthma Education and Prevention Program Asthma and Pregnancy Working Group. NAEPP expert panel report. Managing asthma during pregnancy: recommendations for pharmacologic treatment-2004 update. J Allergy Clin Immunol 2005; 115 (1) 34-46
• 36 Trønnes H, Wilcox AJ, Markestad T, Tollånes MC, Lie RT, Moster D. Associations of maternal atopic diseases with adverse pregnancy outcomes: a national cohort study. Paediatr Perinat Epidemiol 2014; 28 (6) 489-497
• 37 Simpson JL, Scott R, Boyle MJ, Gibson PG. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology 2006; 11 (1) 54-61
• 38 Mendola P, Wallace M, Hwang BS , et al. Preterm birth and air pollution: Critical windows of exposure for women with asthma. J Allergy Clin Immunol 2016; 138 (2) 432-440.e5
• 39 Gent JF, Kezik JM, Hill ME , et al. Asthma medication use during pregnancy, wheeze and estimated exposure to ambient nitrogen dioxide. Eur Respir J 2015; 45 (2) 538-540
• 40 Baribeau V, Beauchesne MF, Rey É, Forget A, Blais L. The use of asthma controller medications during pregnancy and the risk of gestational diabetes. J Allergy Clin Immunol 2016; 138 (6) 1732-1733.e6
• 41 Martel MJ, Rey E, Beauchesne MF , et al. Control and severity of asthma during pregnancy are associated with asthma incidence in offspring: two-stage case-control study. Eur Respir J 2009; 34 (3) 579-587
• 42 Brunst KJ, Rosa MJ, Jara C , et al. Impact of maternal lifetime interpersonal trauma on children's asthma: mediation through maternal active asthma during pregnancy. Psychosom Med 2017; 79 (1) 91-100
• 43 Gade EJ, Thomsen SF, Lindenberg S, Backer V. Fertility outcomes in asthma: a clinical study of 245 women with unexplained infertility. Eur Respir J 2016; 47 (4) 1144-1151
• 44 Gade EJ, Thomsen SF, Lindenberg S, Macklon NS, Backer V. Lower values of VEGF in endometrial secretion are a possible cause of subfertility in non-atopic asthmatic patients. J Asthma 2015; 52 (4) 336-342
• 45 Gade EJ, Thomsen SF, Lindenberg S, Kyvik KO, Lieberoth S, Backer V. Asthma affects time to pregnancy and fertility: a register-based twin study. Eur Respir J 2014; 43 (4) 1077-1085
• 46 Van Zutphen AR, Bell EM, Browne ML, Lin S, Lin AE, Druschel CM ; National Birth Defects Prevention Study. Maternal asthma medication use during pregnancy and risk of congenital heart defects. Birth Defects Res A Clin Mol Teratol 2015; 103 (11) 951-961
• 47 Garne E, Hansen AV, Morris J , et al. Use of asthma medication during pregnancy and risk of specific congenital anomalies: a European case-malformed control study. J Allergy Clin Immunol 2015; 136 (6) 1496-502.e1 , 7
• 48 Garne E, Vinkel Hansen A, Morris J , et al. Risk of congenital anomalies after exposure to asthma medication in the first trimester of pregnancy - a cohort linkage study. BJOG 2016; 123 (10) 1609-1618
• 49 Eltonsy S, Forget A, Blais L. The impact of different case ascertainment definitions on the prevalence of major congenital malformations and their association with asthma during pregnancy. Matern Child Health J 2017; 21 (3) 616-625
• 50 Charlton RA, Snowball JM, Nightingale AL, Davis KJ. Safety of fluticasone propionate prescribed for asthma during pregnancy: a UK population-based cohort study. J Allergy Clin Immunol Pract 2015; 3 (5) 772-9.e3
• 51 Eltonsy S, Forget A, Beauchesne MF, Blais L. Risk of congenital malformations for asthmatic pregnant women using a long-acting b₂-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy. J Allergy Clin Immunol 2015; 135 (1) 123-130
• 52 Tinker SC, Broussard CS, Frey MT, Gilboa SM. Prevalence of prescription medication use among non-pregnant women of childbearing age and pregnant women in the United States: NHANES, 1999-2006. Matern Child Health J 2015; 19 (5) 1097-1106
• 53 Enriquez R, Wu P, Griffin MR , et al. Cessation of asthma medication in early pregnancy. Am J Obstet Gynecol 2006; 195 (1) 149-153
• 54 Lim AS, Stewart K, Abramson MJ, George J. Management of asthma in pregnant women by general practitioners: a cross sectional survey. BMC Fam Pract 2011; 12: 121
• 55 Beau AB, Didier A, Hurault-Delarue C, Montastruc JL, Lacroix I, Damase-Michel C. Prescription of asthma medications before and during pregnancy in France: an observational drug study using the EFEMERIS database. J Asthma 2017; 54 (3) 258-264
• 56 Charlton RA, Pierini A, Klungsøyr K , et al. Asthma medication prescribing before, during and after pregnancy: a study in seven European regions. BMJ Open 2016; 6 (1) e009237
• 57 Murphy VE, Powell H, Wark PA, Gibson PG. A prospective study of respiratory viral infection in pregnant women with and without asthma. Chest 2013; 144 (2) 420-427
• 58 Zairina E, Abramson MJ, McDonald CF , et al. Telehealth to improve asthma control in pregnancy: A randomized controlled trial. Respirology 2016; 21 (5) 867-874
• 59 Murphy VE, Gibson PG, Talbot PI, Kessell CG, Clifton VL. Asthma self-management skills and the use of asthma education during pregnancy. Eur Respir J 2005; 26 (3) 435-441
• 60 Baarnes CB, Hansen AV, Ulrik CS. Enrolment in an asthma management program during pregnancy and adherence with inhaled corticosteroids: the “Management of Asthma during Pregnancy” program. Respiration 2016; 92 (1) 9-15
• 61 Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. Available at: http://ginasthma.org/2016-gina-report-global-strategy-for-asthma-management-and-prevention/ . Accessed February 1, 2017
• 62 British Thoracic Society and Scottish Intercollegiate Guidelines Network. British guideline on the management of ashtma: a national clinical guideline. Available at: https://www.brit-thoracic.org.uk/standards-of-care/guidelines/btssign-british-guideline-on-the-management-of-asthma/ . Accessed February 1, 2017
• 63 Green RH, Brightling CE, McKenna S , et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002; 360 (9347): 1715-1721
• 64 Zhang X-Y, Simpson JL, Powell H , et al. Full blood count parameters for the detection of asthma inflammatory phenotypes. Clin Exp Allergy 2014; 44 (9) 1137-1145
• 65 Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005; 352 (21) 2163-2173
• 66 Essat M, Harnan S, Gomersall T , et al. Fractional exhaled nitric oxide for the management of asthma in adults: a systematic review. Eur Respir J 2016; 47 (3) 751-768
• 67 Petsky HL, Kew KM, Chang AB. Exhaled nitric oxide levels to guide treatment for children with asthma. Cochrane Database Syst Rev 2016; 11: CD011439
• 68 Petsky HL, Cates CJ, Lasserson TJ , et al. A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils). Thorax 2012; 67 (3) 199-208
• 69 Mattes J, Murphy VE, Powell H, Gibson PG. Prenatal origins of bronchiolitis: protective effect of optimised asthma management during pregnancy. Thorax 2014; 69 (4) 383-384
• 70 Murphy VE, Jensen ME, Mattes J , et al. The Breathing for Life Trial: a randomised controlled trial of fractional exhaled nitric oxide (FENO)-based management of asthma during pregnancy and its impact on perinatal outcomes and infant and childhood respiratory health. BMC Pregnancy Childbirth 2016; 16: 111
• 71 Lim A, Stewart K, Abramson MJ, Walker SP, George J. Multidisciplinary approach to management of maternal asthma (MAMMA [copyright]): the PROTOCOL for a randomized controlled trial. BMC Public Health 2012; 12: 1094
• 72 McLaughlin K, Kable A, Ebert L, Murphy V. Midwives' perception of their role in providing antenatal asthma management in Australia--a qualitative study. Midwifery 2016; 35: 11-16
• 73 McLaughlin K, Kable A, Ebert L, Murphy VE. Barriers preventing Australian midwives from providing antenatal asthma management. Br J Midwifery 2015; 23: 32-39
• 74 Chambers K. Asthma education and outcomes for women of childbearing age. Case Manager 2003; 14 (6) 58-61
• 75 Lim AS, Stewart K, Abramson MJ, Walker SP, Smith CL, George J. Multidisciplinary Approach to Management of Maternal Asthma (MAMMA): a randomized controlled trial. Chest 2014; 145 (5) 1046-1054
• 76 McDonald VM, Simpson JL, Higgins I, Gibson PG. Multidimensional assessment of older people with asthma and COPD: clinical management and health status. Age Ageing 2011; 40 (1) 42-49
• 77 McDonald VM, Gibson PG, Scott HA , et al. Should we treat obesity in COPD? The effects of diet and resistance exercise training. Respirology 2016; 21 (5) 875-882
• 78 Powell H, Murphy VE, Hensley MJ, Giles W, Clifton VL, Gibson PG. Rhinitis in pregnant women with asthma is associated with poorer asthma control and quality of life. J Asthma 2015; 52 (10) 1023-1030
• 79 Grzeskowiak LE, Smith B, Roy A , et al. Impact of a history of maternal depression and anxiety on asthma control during pregnancy. J Asthma 2017;
• 80 Murphy VE, Gibson PG. Asthma in pregnancy. Clin Chest Med 2011; 32 (1) 93-110 , ix
• 81 Murphy VE, Mattes J, Powell H, Baines KJ, Gibson PG. Respiratory viral infections in pregnant women with asthma are associated with wheezing in the first 12 months of life. Pediatr Allergy Immunol 2014; 25 (2) 151-158
• 82 Grieger JA, Grzeskowiak LE, Wood LG, Clifton VL. Asthma control in pregnancy is associated with pre-conception dietary patterns. Public Health Nutr 2016; 19 (2) 332-338
• 83 Powell H, McCaffery K, Murphy VE , et al. Psychosocial variables are related to future exacerbation risk and perinatal outcomes in pregnant women with asthma. J Asthma 2013; 50 (4) 383-389